Analyst · VistaGen Therapeutics, Inc. (VTGN) | Ratings, Price Targets & Consensus

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts3

Ratings

Updated Aug 25, 2026

Overall Rating

B

DCF Score5.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.24

Median Target+1799.10%

$4.63

Potential upside vs current price

DCF Value+181.42%

$0.69

Potential upside vs current price

Current Stock Price

$0.24

Median Target+1799.10%

$4.63

Potential upside vs current price

DCF Value+181.42%

$0.69

Potential upside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts3

Ratings

Updated Aug 25, 2026

Overall Rating

B

DCF Score5.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.24

Median Target+1799.10%

$4.63

Potential upside vs current price

DCF Value+181.42%

$0.69

Potential upside vs current price

Current Stock Price

$0.24

Median Target+1799.10%

$4.63

Potential upside vs current price

DCF Value+181.42%

$0.69

Potential upside vs current price